BNP Paribas Financial Markets’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.55K | Sell |
8,199
-2,652
| -24% | -$825 | ﹤0.01% | 4213 |
|
2025
Q1 | $5.31K | Sell |
10,851
-163,800
| -94% | -$80.1K | ﹤0.01% | 4010 |
|
2024
Q4 | $150K | Buy |
174,651
+39,379
| +29% | +$33.7K | ﹤0.01% | 3176 |
|
2024
Q3 | $1.15M | Buy |
135,272
+128,353
| +1,855% | +$1.09M | ﹤0.01% | 1740 |
|
2024
Q2 | $32.3K | Buy |
6,919
+6,918
| +691,800% | +$32.3K | ﹤0.01% | 2886 |
|
2024
Q1 | $7 | Hold |
1
| – | – | ﹤0.01% | 3342 |
|
2023
Q4 | $3 | Sell |
1
-1,632
| -100% | -$4.9K | ﹤0.01% | 3275 |
|
2023
Q3 | $4.07K | Hold |
1,633
| – | – | ﹤0.01% | 2994 |
|
2023
Q2 | $2.09K | Sell |
1,633
-37
| -2% | -$47 | ﹤0.01% | 3102 |
|
2023
Q1 | $1.36K | Sell |
1,670
-1,451
| -46% | -$1.18K | ﹤0.01% | 3028 |
|
2022
Q4 | $2.37K | Buy |
3,121
+2,481
| +388% | +$1.89K | ﹤0.01% | 3060 |
|
2022
Q3 | $595 | Sell |
640
-22,314
| -97% | -$20.7K | ﹤0.01% | 3784 |
|
2022
Q2 | $21.8K | Buy |
22,954
+21,415
| +1,391% | +$20.3K | ﹤0.01% | 3050 |
|
2022
Q1 | $3.25K | Sell |
1,539
-3,311
| -68% | -$6.99K | ﹤0.01% | 3307 |
|
2021
Q4 | $43.4K | Buy |
4,850
+1,715
| +55% | +$15.3K | ﹤0.01% | 3119 |
|
2021
Q3 | $52K | Buy |
3,135
+2,367
| +308% | +$39.3K | ﹤0.01% | 2917 |
|
2021
Q2 | $16K | Sell |
768
-1,249
| -62% | -$26K | ﹤0.01% | 3000 |
|
2021
Q1 | $37.8K | Sell |
2,017
-535
| -21% | -$10K | ﹤0.01% | 3106 |
|
2020
Q4 | $56.2K | Sell |
2,552
-615
| -19% | -$13.5K | ﹤0.01% | 2849 |
|
2020
Q3 | $65.7K | Buy |
3,167
+2,648
| +510% | +$55K | ﹤0.01% | 2717 |
|
2020
Q2 | $18.8K | Sell |
519
-1,936
| -79% | -$70K | ﹤0.01% | 2798 |
|
2020
Q1 | $80.3K | Buy |
2,455
+1,345
| +121% | +$44K | ﹤0.01% | 2713 |
|
2019
Q4 | $30.3K | Buy |
1,110
+1,050
| +1,750% | +$28.6K | ﹤0.01% | 3211 |
|
2019
Q3 | $659 | Buy |
+60
| New | +$659 | ﹤0.01% | 3767 |
|